XLO - Xilio Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Xilio Therapeutics, Inc. Common Stock
IPO Date: October 18, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $59.29M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.20 | 5.12%
Avg Daily Range (30 D): $0.13 | 1.44%
Avg Daily Range (90 D): $0.16 | 1.82%
Institutional Daily Volume
Avg Daily Volume: .47M
Avg Daily Volume (30 D): .01M
Avg Daily Volume (90 D): .02M
Trade Size
Avg Trade Size (Sh.): 358
Avg Trade Size (Sh.) (30 D): 91
Avg Trade Size (Sh.) (90 D): 78
Institutional Trades
Total Institutional Trades: 19
Avg Institutional Trade: $2.18M
Avg Institutional Trade (30 D): $4.6M
Avg Institutional Trade (90 D): $4.6M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $4.69M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 42.67K
 
News
Oct 2, 2026 @ 8:30 PM
Xilio Therapeutics Announces Inducement Grants Und...
Source: Na
Sep 2, 2026 @ 8:30 PM
Xilio Therapeutics Announces Inducement Grants Und...
Source: Na
Apr 3, 2026 @ 8:30 PM
Xilio Therapeutics Announces Inducement Grants Und...
Source: Na
Feb 12, 2026 @ 2:34 AM
Xilio Therapeutics Announces Pricing of Underwritt...
Source: Not Specified
Oct 3, 2025 @ 1:00 PM
Xilio Therapeutics Announces Upcoming Presentation...
Source: Xilio Therapeutics
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.33 $-.58 $-3.76
Diluted EPS $-.33 $-.58 $-3.76
Revenue $18.69M $12.65M $13.69M
Gross Profit
Net Income / Loss $-6.37M $-9.53M $10.36M
Operating Income / Loss $-3.49M $-14.11M $-11.84M
Cost of Revenue
Net Cash Flow $-14.29M $12.81M $33.77M
PE Ratio    
Splits
Mar 16, 2026 1:14